IKOP Pharma Wins The BrandLaureate Awards 2026: Strengthening the Position of IIUM Holdings in the Pharmaceutical Industry
KUALA LUMPUR, 29 April 2026 – The IIUM Holdings Sdn Bhd family celebrates another historic achievement as its subsidiary, IKOP Pharma, won the prestigious award, The BrandLaureate Awards 2026.
The glittering ceremony, held at The Majestic Hotel, Kuala Lumpur on Wednesday, saw IKOP Pharma receive recognition in the Manufacturing OEM Pharmaceutical Solution category.
Commitment to Halal Pharmaceutical Standards
This world-class recognition is clear evidence of the continued commitment of the Group to driving the highest standards for the Halal pharmaceutical industry in Malaysia. As a key player in the pharmaceutical manufacturing sector, IKOP Pharma consistently ensures every OEM solution offered meets global quality standards without compromising Shariah integrity.
This success reflects not only operational excellence, but also the result of outstanding synergy and dedication from the entire workforce under IIUM Holdings.
Driving the #RISE2030 Vision and IIUM Holdings Silver Jubilee
This achievement comes at a truly meaningful time for us. Coinciding with the celebration of the IIUM Holdings 25th Anniversary (Silver Jubilee), this award serves as a catalyst for us to continue realising the #RISE2030 vision.
Through this vision, IIUM Holdings is committed to:
- Continuously innovating in the healthcare sector.
- Delivering the best value to the community through safe and trusted pharmaceutical products.
- Strengthening the national economy through the empowerment of the local Halal industry.
Congratulations, Team IKOP Pharma!
IIUM Holdings senior management extends its heartiest congratulations to the entire IKOP Pharma team. Your dedication has placed the company at the pinnacle of excellence. May this recognition from The BrandLaureate inspire us to keep "flying high" and delivering a positive impact to the nation.